Abstract
This chapter covers main provisions on diagnosis and treatment approaches in patients with drug-induced pulmonary diseases (DIPD). The most frequent DIPD variants are amiodarone lung and methotrexate-induced interstitial lung disease, and lung lesions caused by anticancer drugs are also considered. Additionally, clinical and radiological patterns of DIPD and aspects of bronchoalveolar lavage and criteria for differential diagnosis are considered.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
